Page last updated: 2024-11-05

trihexyphenidyl and Cerebral Arteriosclerosis

trihexyphenidyl has been researched along with Cerebral Arteriosclerosis in 3 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
TURNER, JW	1
Evtushenko, SK	1
Gol'dovskaia, IL	1

Other Studies

3 other studies available for trihexyphenidyl and Cerebral Arteriosclerosis

Article	Year
PARKINSONISM: AETIOLOGY AND TREATMENT. London Clinic medical journal, 1964, Volume: 5 Topics: Carbon Monoxide Poisoning; Craniocerebral Trauma; Drug Therapy; Encephalitis; Intracranial Arteriosc	1964
[Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1976, Volume: 76, Issue:12 Topics: Acetylcholine; Adult; Aged; Amantadine; Antiparkinson Agents; Cholinesterases; Drug Therapy, Combina	1976
[The possibilities and limitations of psychotropic drug therapy for patients with glaucoma]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1974, Volume: 74, Issue:9 Topics: Aged; Alcoholism; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Chronic Disease; Dementia;	1974